Scientific Advisory Board
Henry F. McFarland, M.D.
Scientific Director, Cumming Foundation
Dr. McFarland attended undergraduate school at the University of Arizona and medical school at the University of Colorado. He then completed a medical internship and neurology residency at Thomas Jefferson University. Following residency, Dr. McFarland did a fellowship in neurovirology at Johns Hopkins University School of Medicine and a fellowship in Immunology at the Laboratory of Tumor Biology, University College, London. Following his fellowships, Dr. McFarland returned to the faculty of the Department of Neurology, Johns Hopkins School of Medicine. In 1975, Dr. McFarland moved to NIH to join the newly formed Neuroimmunology Branch as the Deputy Chief of the Branch. In 1994, Dr. McFarland became Chief of the Neuroimmunology Branch where he remained until 2009 when he retired and became Scientist Emeritus. Dr. McFarland’s research interests have included studies of the genetic influence in multiple sclerosis (MS), studies of immune mechanisms in MS and most recently, use of MRI to study the natural history of MS. Dr. McFarland served as Clinical Director, NINDS, from 2001–2007.
Dr. McFarland has published over 250 papers dealing with the cause and treatment of multiple sclerosis. Dr. McFarland is also a co-editor of one of the standard texts on MS. He was elected a member of the American Neurological Association in 1991. Dr. McFarland has received the Dystal Award for outstanding research in multiple sclerosis in 1998 awarded jointly by the American Academy of Neurology and the National Multiple Sclerosis Society (NMSS). He was selected as the Soriano Lecturer at the American Neurological Association in 1996. In 2003, Dr. McFarland was awarded the Charcot Award for lifetime achievement in research in MS by the Multiple Sclerosis International Federation. He has served on numerous advisory committees for the National Multiple Sclerosis Society (NMSS) and is currently on the Board of Directors for the NMSS, as well as for the National Capital Chapter of the NMSS. At NIH, he served as Chair of the Medical Executive Committee as well as the Advisory Board for Clinical Research that is advisory to the Director, NIH in shaping the future direction of clinical research at NIH.
Daniel S. Reich, M.D., Ph.D.
Chief, Translational Neuroradiology Unit, National Institute of Neurological Disorders and Stroke, National Institute of Health
After studying math and physics at Yale (1993), Dr. Reich earned a Ph.D. in visual neurophysiology at The Rockefeller University (2000) and an M.D. from Cornell University (2002). He subsequently completed residencies in neurology and diagnostic radiology and a clinical fellowship in neuroradiology at the Johns Hopkins Hospital. He is currently board-certified in both neurology and diagnostic radiology. He performed postdoctoral research under the simultaneous supervision of Peter Calabresi and Susumu Mori at Johns Hopkins, during which he applied MRI, particularly diffusion-weighted imaging, to study multiple sclerosis. The focus of the Translational Neuroradiology Unit is to develop new MRI methods to investigate the origin of disability in multiple sclerosis and related disorders and to apply those methods to patient care and to clinical trials of new drugs.
Monica J Carson, Ph.D.
Professor and Chair, Division of Biomedical Sciences, UC Riverside, School of Medicine
Monica J Carson, PhD is Professor and Chair of the Division of Biomedical Sciences at the University of California Riverside (UCR) School of Medicine. She also serves as the Director of UCR’s Center for Glial-Neuronal Interactions and as Editor-in-Chief for ASN NEURO, the official journal of the American Society for Neurochemistry. Her research has focused on microglial biology, multiple sclerosis and neurodegeneration since her graduate studies.
Anne Cross, M.D.
Professor Neurology, Section Head of Neuroimmunology, Washington University
Anne H. Cross MD graduated summa cum laude from the University of South Alabama with a B.S. in chemistry and cum laude from the University of Alabama School of Medicine, where she was selected for the Alpha Omega Alpha medical honorary. She did neurology residency training at George Washington University, serving as Chief Resident in her final year. Dr. Cross then trained in clinical multiple sclerosis and neuroimmunology at the National Institute of Health and in neuroimmunology and neuropathology at Albert Einstein School of Medicine in New York. She was named a Harry Weaver Neuroscience Scholar of the National Multiple Sclerosis Society. She joined the faculty of Washington University in 1991, as a specialist in MS and neuroimmunology. Her research interests are in the roles of B cells and antibodies in MS and its animal models, the role of adipokines in regulation of neuroimmunologic disorders, and the development of imaging techniques to identify and quantitate demyelination, axonal loss and inflammation in the CNS of animals and patients.